Treating herpes simplex virus type 2 (HSV-2) with valacyclovir (Valtrex) was associated with a substantial reduction in plasma hepatitis C virus levels in dually-infected individuals, according to a small study presented at the Digestive Disease Week conference (DDW 2013)this week in Orlando.
Mary Jane Burton from the G.V. Sonny Montgomery VA Medical Center in Jackson, Mississippi, and colleagues performed a pilot study to evaluate the safety and impact of valacyclovir on HCV levels in veterans with HSV-2 and HCV coinfection
Continue reading @ HIV and Hepatitis
No comments:
Post a Comment